Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DDL
11951
PUT
Dingdong
DDL
$470M
| $103K | ﹤0.01% |
40,100
+17,700
| +79% | +$49.2K |
2025 Q4
1 quarter
|
|
11952
PUT
Gray Television
GTN
$468M
| $103K | ﹤0.01% |
23,700
+7,600
| +47% | +$35.7K |
2021 Q1
20 quarters
|
|
|
CMRC
11953
CALL
Commerce.com Inc Series 1
CMRC
$269M
| $103K | ﹤0.01% |
38,500
+14,300
| +59% | +$44.5K |
2025 Q4
1 quarter
|
|
|
CCII
11954
Cohen Circle Acquisition Corp II
CCII
$358M
| $103K | ﹤0.01% |
+10,057
| New | +$103K |
2026 Q1
0 quarters
|
|
11955
CALL
Immuneering
IMRX
$263M
| $103K | ﹤0.01% |
19,500
-32,200
| -62% | -$165K |
2025 Q4
1 quarter
|
|
11956
PUT
Ocugen
OCGN
$346M
| $102K | ﹤0.01% |
56,500
+11,200
| +25% | +$19.4K |
2021 Q1
20 quarters
|
|
11957
PUT
SAB Biotherapeutics
SABS
$271M
| $102K | ﹤0.01% |
+26,700
| New | +$106K |
2026 Q1
0 quarters
|
|
|
HIO
11958
Western Asset High Income Opportunity Fund
HIO
$313M
| $102K | ﹤0.01% |
+28,169
| New | +$105K |
2026 Q1
0 quarters
|
|
|
ARTV
11959
Artiva Biotherapeutics
ARTV
$334M
| $102K | ﹤0.01% |
+15,870
| New | +$78.5K |
2026 Q1
0 quarters
|
|
|
MIN
11960
Aberdeen Intermediate Income Fund
MIN
$265M
| $102K | ﹤0.01% |
40,648
-73,103
| -64% | -$188K |
2025 Q4
1 quarter
|
|
11961
Precision Optics
POCI
$48.9M
| $102K | ﹤0.01% |
23,235
+1,173
| +5% | +$5.37K |
2025 Q3
2 quarters
|
|
11962
Culp Inc
CULP
$49.5M
| $102K | ﹤0.01% |
+37,103
| New | +$124K |
2026 Q1
0 quarters
|
|
|
BDCIU
11963
BTC Development Corp Unit
BDCIU
| $102K | ﹤0.01% |
10,073
| – | – |
2025 Q4
1 quarter
|
|
|
SNBR
11964
DELISTED
Sleep Number
SNBR
| $102K | ﹤0.01% |
56,585
+8,123
| +17% | +$61.1K |
2025 Q1
4 quarters
|
|
|
SSACU
11965
SPACSphere Acquisition Corp Unit
SSACU
$158M
| $101K | ﹤0.01% |
+10,056
| New | +$101K |
2026 Q1
0 quarters
|
|
11966
CALL
CPS Technologies
CPSH
$74.4M
| $101K | ﹤0.01% |
27,000
+8,100
| +43% | +$35.9K |
2025 Q1
4 quarters
|
|
11967
PUT
Innoviz Technologies
INVZ
$108M
| $101K | ﹤0.01% |
159,600
-10,200
| -6% | -$9.32K |
2021 Q2
19 quarters
|
|
|
CRMG
11968
PUT
Leverage Shares 2X Long CRM Daily ETF
CRMG
$50.1M
| $101K | ﹤0.01% |
16,000
+3,000
| +23% | +$24.6K |
2025 Q3
2 quarters
|
|
|
CMMB
11969
Chemomab Therapeutics
CMMB
$10.5M
| $101K | ﹤0.01% |
64,182
-39,599
| -38% | -$67.7K |
2025 Q4
1 quarter
|
|
11970
CALL
Invivyd
IVVD
$242M
| $101K | ﹤0.01% |
77,500
-71,200
| -48% | -$131K |
2025 Q3
2 quarters
|
|
|
SNBR
11971
PUT
DELISTED
Sleep Number
SNBR
| $101K | ﹤0.01% |
56,100
-21,400
| -28% | -$161K |
2013 Q2
51 quarters
|
|
11972
CALL
Actinium Pharmaceuticals
ATNM
$36.8M
| $101K | ﹤0.01% |
101,100
-13,600
| -12% | -$16.2K |
2020 Q4
21 quarters
|
|
11973
AYTU BioPharma
AYTU
$22.5M
| $101K | ﹤0.01% |
36,841
+21,290
| +137% | +$54.4K |
2025 Q4
1 quarter
|
|
|
INCR
11974
Intercure
INCR
$81.3M
| $101K | ﹤0.01% |
26,784
+13,533
| +102% | +$59K |
2021 Q3
18 quarters
|
|
11975
CALL
Hyliion Holdings
HYLN
$809M
| $100K | ﹤0.01% |
57,100
+44,500
| +353% | +$89.5K |
2020 Q3
22 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.